Confident Investing Starts Here:
- Quickly and easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
Konica Minolta ( (JP:4902) ) just unveiled an announcement.
Konica Minolta reported its consolidated financial results for the fiscal year ending March 31, 2025, showing a slight increase in revenue but a significant decline in operating profit and overall profitability compared to the previous year. The company has classified its Precision Medicine Business as a discontinued operation, impacting its financial metrics. The results indicate challenges in maintaining profitability, with a notable decrease in total assets and equity, and a negative cash flow from financing activities, which may affect stakeholders’ confidence.
The most recent analyst rating on (JP:4902) stock is a Buy with a Yen750.00 price target. To see the full list of analyst forecasts on Konica Minolta stock, see the JP:4902 Stock Forecast page.
More about Konica Minolta
Konica Minolta, Inc. is a company listed on the Tokyo Stock Exchange, primarily involved in the technology industry. The company is known for its products and services in imaging, precision medicine, and other technology-driven solutions.
Average Trading Volume: 3,217,556
Technical Sentiment Signal: Sell
Current Market Cap: Yen230.9B
For an in-depth examination of 4902 stock, go to TipRanks’ Stock Analysis page.